Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:pharmaceuticals
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:available_on |
gptkb:pharmaceuticals
|
| gptkbp:chemical_formula |
C9 H13 N5 O
|
| gptkbp:developed_by |
hypertension
|
| gptkbp:discovered_by |
1960s
|
| gptkbp:dosage_form |
2% solution
5% solution |
| gptkbp:effectiveness_duration |
4 to 6 months
|
| gptkbp:formulation |
foam
topical solution |
| https://www.w3.org/2000/01/rdf-schema#label |
minoxidil
|
| gptkbp:ingredients |
minoxidil sulfate
|
| gptkbp:invention |
gptkb:1996
|
| gptkbp:marketed_as |
gptkb:Rogaine
Regaine |
| gptkbp:mechanism_of_action |
vasodilator
|
| gptkbp:service_frequency |
twice daily
|
| gptkbp:side_effect |
dizziness
rapid heartbeat scalp irritation unwanted facial hair growth |
| gptkbp:suitable_for |
gptkb:children
pregnant women nursing mothers |
| gptkbp:used_by |
both men and women
|
| gptkbp:used_for |
hair loss treatment
|
| gptkbp:bfsParent |
gptkb:Rogaine
gptkb:alopecia_areata |
| gptkbp:bfsLayer |
6
|